Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ADXNAddex Therapeutics Ltd.

Nasdaq · CIK 0001574232
Filer categoryNon-accelerated filer
Entity typeother
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts196

Identity from submissions API

NameAddex Therapeutics Ltd.
CIK0001574232
TickersADXN
ExchangesNasdaq
Entity typeother
CategoryNon-accelerated filer
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationV8 Switzerland
Phone01141228841555
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
CHEMIN DES MINES 9
GENEVA
V8
CH-1202
Switzerland
Mailing address
CHEMIN DES MINES 9
GENEVA
V8
CH-1202
Switzerland

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

289 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 4/A OWNERSHIP DOCUMENT 0001104659-26-128219 6401
2026-11-16 4/A OWNERSHIP DOCUMENT 0001104659-26-128208 6407
2026-11-13 4 OWNERSHIP DOCUMENT 0001104659-26-127029 5962
2026-11-13 4 OWNERSHIP DOCUMENT 0001104659-26-127027 5958
2026-11-13 4 OWNERSHIP DOCUMENT 0001104659-26-127026 5956
2026-11-13 4 OWNERSHIP DOCUMENT 0001104659-26-127023 5979
2026-11-13 4 OWNERSHIP DOCUMENT 0001104659-26-127020 5963
2026-11-13 4 OWNERSHIP DOCUMENT 0001104659-26-127014 5856
2026-11-13 4 OWNERSHIP DOCUMENT 0001104659-26-127010 5960
2026-11-12 6-K FORM 6-K 0001171843-26-007354 001-39179 261542534 34 15591
2026-10-29 6-K FORM 6-K 0001171843-26-006946 001-39179 261497246 34 14803
2026-10-08 6-K FORM 6-K 0001171843-26-006524 001-39179 261448186 34 16143
2026-10-02 6-K FORM 6-K 0001171843-26-006345 001-39179 261433365 34 17579
2026-09-28 6-K 6-K 0001104659-26-111142 001-39179 261411967 34 7664676 1 1
2026-09-25 6-K FORM 6-K 0001171843-26-006225 001-39179 261406103 34 18089
2026-09-04 4 OWNERSHIP DOCUMENT 0001104659-26-105509 39185
2026-09-04 4 OWNERSHIP DOCUMENT 0001104659-26-105506 12349
2026-09-04 4 OWNERSHIP DOCUMENT 0001104659-26-105501 12317
2026-09-04 4 OWNERSHIP DOCUMENT 0001104659-26-105496 12322
2026-09-04 4 OWNERSHIP DOCUMENT 0001104659-26-105491 12211
2026-09-04 4 OWNERSHIP DOCUMENT 0001104659-26-105489 12337
2026-09-04 4 OWNERSHIP DOCUMENT 0001104659-26-105484 12326
2026-09-04 4 OWNERSHIP DOCUMENT 0001104659-26-105481 12305
2026-09-04 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-105480 005-91805 261362011 34 19234
2026-08-27 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-101798 005-91805 261324855 34 17540
2026-08-26 6-K FORM 6-K 0001171843-26-005744 001-39179 261317504 34 13908
2026-07-08 6-K FORM 6-K 0001171843-26-004524 001-39179 261160718 34 16860
2026-06-30 6-K FORM 6-K 0001171843-26-004375 001-39179 261137886 34 16190
2026-06-25 6-K FORM 6-K 0001104659-26-077470 001-39179 261117518 34 626049
2026-06-05 6-K FORM 6-K 0001171843-26-003926 001-39179 261066774 34 17165
2026-05-15 20-F FORM 20-F 0001104659-26-062447 001-39179 26986621 34 17816115 1 1
2026-04-30 NT 20-F NT 20-F 0001104659-26-052854 001-39179 26924818 34 31181
2026-04-30 6-K FORM 6-K 0001171843-26-002871 001-39179 26919742 34 27570
2026-04-29 6-K FORM 6-K 0001171843-26-002787 001-39179 26910290 34 16586
2026-04-23 6-K FORM 6-K 0001171843-26-002661 001-39179 26885384 34 18334
2026-04-21 6-K FORM 6-K 0001171843-26-002589 001-39179 26876649 34 16910
2026-03-25 3 OWNERSHIP DOCUMENT 0001104659-26-034503 13852
2026-03-25 3 OWNERSHIP DOCUMENT 0001104659-26-034501 14214
2026-03-25 3 OWNERSHIP DOCUMENT 0001104659-26-034498 12365
2026-03-25 3 OWNERSHIP DOCUMENT 0001104659-26-034495 13954
2026-03-25 3 OWNERSHIP DOCUMENT 0001104659-26-034491 13852
2026-03-18 3 OWNERSHIP DOCUMENT 0001104659-26-030243 5375
2026-03-18 3 OWNERSHIP DOCUMENT 0001104659-26-030242 13647
2026-03-18 3 OWNERSHIP DOCUMENT 0001104659-26-030240 13894
2026-02-03 6-K FORM 6-K 0001171843-26-000580 001-39179 26590038 34 18851
2026-01-07 6-K FORM 6-K 0001171843-26-000110 001-39179 26513898 34 16709
2025-12-10 6-K FORM 6-K 0001104659-25-119971 001-39179 251561954 34 78293
2025-12-10 424B5 424B5 0001104659-25-119967 333-291644 251561913 33 1147051
2025-12-05 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003556 333-291644 251554498 33 1708
2025-12-04 6-K FORM 6-K 0001104659-25-118226 001-39179 251548168 34 1214729
2025-12-03 CORRESP filename1.htm 0001104659-25-118120 8952
2025-11-19 F-3 F-3 0001104659-25-114077 333-291644 251499280 33 1204644 1 1
2025-10-29 6-K FORM 6-K 0001171843-25-006744 001-39179 251426707 34 13656
2025-09-30 6-K FORM 6-K 0001104659-25-094663 001-39179 251358039 34 9614394 1 1
2025-09-23 6-K FORM 6-K 0001171843-25-006022 001-39179 251331662 34 13190
2025-06-30 6-K FORM 6-K 0001171843-25-004208 001-39179 251088644 34 15489
2025-06-25 6-K FORM 6-K 0001171843-25-004087 001-39179 251070813 34 13486
2025-06-23 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-061660 005-91805 251064886 34 16817
2025-06-20 6-K FORM 6-K 0001104659-25-060772 001-39179 251058908 34 687559
2025-06-06 6-K FORM 6-K 0001171843-25-003746 001-39179 251028767 34 15291
2025-05-15 20-F FORM 20-F 0001104659-25-049380 001-39179 25952429 34 18750994 1 1
2025-05-12 6-K FORM 6-K 0001171843-25-003038 001-39179 25932426 34 15045
2025-04-30 NT 20-F NT 20-F 0001104659-25-042472 001-39179 25894728 34 33840
2025-04-30 6-K FORM 6-K 0001171843-25-002621 001-39179 25890655 34 15603
2025-04-25 6-K FORM 6-K 0001171843-25-002501 001-39179 25869784 34 1238567
2025-04-17 6-K FORM 6-K 0001171843-25-002264 001-39179 25844234 34 13136
2024-11-22 6-K FORM 6-K 0001104659-24-121730 001-39179 241486254 34 1092040
2024-11-12 6-K FORM 6-K 0001171843-24-006203 001-39179 241442791 34 14843
2024-09-30 6-K FORM 6-K 0001104659-24-103840 001-39179 241336426 34 1399665
2024-09-19 6-K FORM 6-K 0001171843-24-005259 001-39179 241308755 34 14652
2024-08-27 6-K FORM 6-K 0001171843-24-004935 001-39179 241243120 34 14613
2024-08-14 SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#7E) 0001072613-24-000634 005-91805 241210254 34 121531
2024-08-05 SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#6) 0001072613-24-000602 005-91805 241176765 34 356505
2024-07-22 6-K FORM 6-K 0001171843-24-004045 001-39179 241129159 34 15691
2024-07-15 6-K FORM 6-K 0001171843-24-003933 001-39179 241115783 34 14993
2024-07-01 6-K FORM 6-K 0001171843-24-003723 001-39179 241087963 34 14386
2024-06-06 6-K FORM 6-K 0001104659-24-068801 001-39179 241023761 34 849899
2024-06-05 6-K FORM 6-K 0001171843-24-003305 001-39179 241020635 34 16841
2024-04-29 6-K FORM 6-K 0001171843-24-002302 001-39179 24886371 34 16336
2024-04-24 424B3 424B3 0001104659-24-051210 333-271611 24870481 33 1490234
2024-04-22 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-24-048823,2024-04-22 9999999995-24-001061 333-271611 24862583 33 1727
2024-04-18 POS AM POS AM 0001104659-24-048823 333-271611 24854252 33 1615430
2024-04-18 20-F FORM 20-F 0001104659-24-048532 001-39179 24852737 34 15862961 1 1
2024-04-18 6-K FORM 6-K 0001171843-24-002070 001-39179 24852720 34 23456
2024-04-03 6-K FORM 6-K 0001171843-24-001785 001-39179 24816770 34 19310
2024-01-30 424B5 424B5 0001104659-24-008319 333-255089 24579010 33 1201688
2024-01-30 6-K FORM 6-K 0001104659-24-008318 001-39179 24578973 34 275424
2023-12-21 6-K/A FORM 6-K/A 0001104659-23-127862 001-39179 231502714 34 6637101 1 1
2023-12-20 6-K FORM 6-K 0001171843-23-007632 001-39179 231499329 34 13134
2023-12-14 6-K FORM 6-K 0001171843-23-007563 001-39179 231485497 34 13627
2023-12-08 SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#5) 0001072613-23-000611 005-91805 231474978 34 311315
2023-11-30 424B3 424B3 0001104659-23-122406 333-271611 231455665 33 496626
2023-11-29 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-23-121793,2023-11-29 9999999995-23-003479 333-271611 231453846 33 1679
2023-11-29 SC 13D/A SC 13D/A 0001104659-23-122019 005-91805 231452091 34 58389
2023-11-29 POS AM POS AM 0001104659-23-121793 333-271611 231448389 33 612152
2023-11-29 6-K FORM 6-K 0001104659-23-121737 001-39179 231448284 34 1225103
2023-11-28 6-K FORM 6-K 0001171843-23-007294 001-39179 231441787 34 13281
2023-11-14 6-K FORM 6-K 0001171843-23-007060 001-39179 231401332 34 17070
2023-11-08 6-K FORM 6-K 0001171843-23-006845 001-39179 231385801 34 13360
2023-10-23 424B3 424B3 0001104659-23-110607 333-271611 231338417 33 500252
2023-10-20 6-K FORM 6-K 0001171843-23-006324 001-39179 231335908 34 14661
2023-10-06 F-6 POS e618986_f6pos-addex.htm 0001193805-23-001379 333-235561 231314513 33 673830
2023-10-06 6-K FORM 6-K 0001171843-23-006132 001-39179 231314191 34 15354
2023-09-20 6-K FORM 6-K 0001171843-23-005796 001-39179 231265229 34 17040
2023-09-05 6-K FORM 6-K 0001171843-23-005543 001-39179 231234048 34 17153
2023-09-05 6-K FORM 6-K 0001171843-23-005540 001-39179 231234045 34 16209
2023-08-11 424B3 424B3 0001104659-23-090450 333-271611 231163854 33 1324115
2023-08-10 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-23-089769,2023-08-10 9999999995-23-002338 333-271611 231161367 33 1679
2023-08-10 POS AM POS AM 0001104659-23-089769 333-271611 231159114 33 1621882
2023-08-10 6-K FORM 6-K 0001104659-23-089501 001-39179 231157090 34 1080761
2023-08-03 6-K FORM 6-K 0001171843-23-004937 001-39179 231137858 34 14943
2023-07-24 6-K FORM 6-K 0001171843-23-004600 001-39179 231103655 34 16949
2023-06-15 6-K FORM 6-K 0001171843-23-003938 001-39179 231015889 34 13695
2023-06-08 S-8 FORM S-8 0001104659-23-069380 333-272515 231001922 33 132138
2023-06-02 EFFECT xslEFFECTX01/primary_doc.xml F-1,,2023-06-02 16:00:00 9999999995-23-001619 333-271611 23991113 33 1665
2023-06-02 424B3 424B3 0001104659-23-067594 333-271611 23989410 33 549383
2023-06-01 CORRESP filename1.htm 0001104659-23-067025 7567
2023-06-01 F-1/A FORM F-1/A 0001104659-23-067020 333-271611 23984616 33 801808
2023-06-01 6-K FORM 6-K 0001171843-23-003680 001-39179 23982929 34 14930
2023-05-18 6-K FORM 6-K 0001171843-23-003402 001-39179 23933637 34 14002
2023-05-12 CORRESP filename1.htm 0001104659-23-059720 7437
2023-05-11 CORRESP filename1.htm 0001104659-23-059144 7114
2023-05-11 F-1/A F-1/A 0001104659-23-059096 333-271611 23910790 33 644178
2023-05-11 6-K FORM 6-K 0001104659-23-058681 001-39179 23908621 34 670883
2023-05-10 6-K FORM 6-K 0001171843-23-003121 001-39179 23904168 34 16973
2023-05-09 UPLOAD filename1.pdf 0000000000-23-004854 40164
2023-05-05 6-K FORM 6-K 0001171843-23-002923 001-39179 23891067 34 14647
2023-05-03 F-1 F-1 0001104659-23-055487 333-271611 23883681 33 712633
2023-04-13 D xslFormDX01/primary_doc.xml 06b 0001231919-23-000017 021-478677 23817114 33 12858
2023-04-10 SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#4) 0001072613-23-000298 005-91805 23811204 34 335934
2023-04-05 SC 13D/A SC 13D/A 0001104659-23-042133 005-91805 23802393 34 54153
2023-04-04 424B5 424B5 0001104659-23-041624 333-255089 23799450 33 1625270
2023-04-04 6-K FORM 6-K 0001104659-23-041530 001-39179 23798070 34 721099
2023-04-04 6-K FORM 6-K 0001171843-23-002102 001-39179 23795017 34 15856
2023-04-03 6-K FORM 6-K 0001171843-23-002052 001-39179 23790287 34 16706
2023-03-31 SC 13D/A SC 13D/A 0001104659-23-040143 005-91805 23787334 34 51476
2023-03-30 6-K FORM 6-K 0001171843-23-001991 001-39179 23777028 34 23179
2023-03-30 20-F FORM 20-F 0001104659-23-038581 001-39179 23777022 34 15521429 1 1
2023-02-16 SC 13G/A armistice-adxn123122a2.htm 0001172661-23-001496 005-91805 23638121 34 91740
2023-02-14 SC 13G/A d9939896_13g-a.htm 0000919574-23-001480 005-91805 23625600 34 124387
2023-02-14 SC 13G/A armistice-adxn123122a1.htm 0001172661-23-001034 005-91805 23625073 34 90871
2023-02-09 6-K FORM 6-K 0001171843-23-000819 001-39179 23600964 34 13859
2023-02-08 SC 13G/A ADDEX_THERAPEUTICS.txt 0000769993-23-000098 005-91805 23596427 34 23685
2023-02-06 SC 13G/A SC 13G/A 0001193125-23-025648 005-91805 23591125 34 98439
2023-02-06 6-K FORM 6-K 0001171843-23-000693 001-39179 23588254 34 17311
2023-01-19 6-K FORM 6-K 0001171843-23-000320 001-39179 23535857 34 16339
2022-12-08 6-K FORM 6-K 0001171843-22-007896 001-39179 221451347 34 16594
2022-11-28 SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A3 0001072613-22-000649 005-91805 221424906 34 335426
2022-11-23 SC 13D/A SC 13D/A 0001104659-22-121418 005-91805 221412175 34 56791
2022-11-22 424B3 424B3 0001104659-22-120912 333-262050 221407372 33 1123050
2022-11-16 424B3 424B3 0001104659-22-119360 333-266995 221393046 33 960419
2022-11-14 6-K FORM 6-K 0001104659-22-117358 001-39179 221379483 34 986464
2022-11-09 SC 13D/A SC 13D/A 0001104659-22-116458 005-91805 221372410 34 52319
2022-11-03 6-K FORM 6-K 0001171843-22-007037 001-39179 221355979 34 14633
2022-11-01 6-K FORM 6-K 0001171843-22-006933 001-39179 221348357 34 28130
2022-09-14 6-K/A FORM 6-K/A 0001104659-22-099810 001-39179 221242014 34 7064485 1 1
2022-08-30 424B3 424B3 0001104659-22-096021 333-266995 221214551 33 1107938
2022-08-29 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-22-094025,2022-08-29 9999999995-22-002531 333-262050 221212817 33 1679
2022-08-29 EFFECT xslEFFECTX01/primary_doc.xml F-1,,2022-08-29 16:00:00 9999999995-22-002544 333-266995 221212810 33 1666
2022-08-25 CORRESP filename1.htm 0001104659-22-094419 8468
2022-08-25 UPLOAD filename1.pdf 0000000000-22-009203 40126
2022-08-24 POS AM POS AM 0001104659-22-094025 333-262050 221191581 33 1248138
2022-08-23 SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A2 0001072613-22-000523 005-91805 221188313 34 337166
2022-08-19 F-1 F-1 0001104659-22-093004 333-266995 221181437 33 1485502
2022-08-18 6-K FORM 6-K 0001104659-22-092309 001-39179 221176269 34 986803
2022-08-15 6-K FORM 6-K 0001171843-22-005651 001-39179 221162091 34 19546
2022-08-05 SC 13D/A SC 13D/A 0001104659-22-086368 005-91805 221138442 34 54443
2022-08-04 D xslFormDX01/primary_doc.xml 06b 0001231919-22-000052 021-454872 221135631 33 13716
2022-07-26 6-K FORM 6-K 0001104659-22-082772 001-39179 221107185 34 541933
2022-07-26 424B5 424B5 0001104659-22-082766 333-255089 221107118 33 2124302
2022-07-22 6-K FORM 6-K 0001171843-22-004952 001-39179 221098373 34 16136
2022-07-21 6-K FORM 6-K 0001171843-22-004927 001-39179 221095492 34 16351
2022-07-21 6-K FORM 6-K 0001171843-22-004926 001-39179 221095493 34 13941
2022-07-20 424B5 424B5 0001104659-22-080927 333-262050 221092592 33 1163587
2022-06-17 6-K FORM 6-K 0001171843-22-004400 001-39179 221022341 34 14622
2022-05-27 6-K FORM 6-K 0001171843-22-003993 001-39179 22972468 34 17229
2022-05-10 6-K FORM 6-K 0001171843-22-003474 001-39179 22907206 34 16209
2022-05-05 6-K FORM 6-K 0001104659-22-056038 001-39179 22893816 34 717837
2022-04-19 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-22-039084,2022-04-19 9999999995-22-001013 333-235554 22836238 33 1678
2022-04-13 6-K FORM 6-K 0001171843-22-002560 001-39179 22823567 34 16437
2022-04-06 6-K FORM 6-K 0001171843-22-002409 001-39179 22809309 34 15074
2022-04-04 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-22-041024,2022-04-04 9999999995-22-000815 333-262050 22805085 33 1678
2022-03-31 POS AM POS AM 0001104659-22-041024 333-262050 22792562 33 1401727
2022-03-31 6-K FORM 6-K 0001171843-22-002201 001-39179 22788983 34 15914
2022-03-29 CORRESP filename1.htm 0001104659-22-039088 23405
2022-03-29 POS AM POS AM 0001104659-22-039084 333-235554 22777364 33 50285
2022-03-10 6-K FORM 6-K 0001171843-22-001750 001-39179 22727297 34 25176
2022-03-10 20-F 20-F 0001104659-22-032171 001-39179 22727281 34 13563967 1 1
2022-02-18 SC 13G/A SC 13G/A - AMENDMENT NO. 2 0001193125-22-046701 005-91805 22653596 34 98940
2022-02-15 SC 13G SC 13G 0001193125-22-042412 005-91805 22635946 34 69486
2022-02-14 SC 13G/A d9177801_13g-a.htm 0000919574-22-001580 005-91805 22631661 34 125410
2022-02-14 SC 13G ADDEX THERAPEUTICS 0000769993-22-000232 005-91805 22630594 34 23457
2022-02-14 SC 13G/A NONE 0001567619-22-004128 005-91805 22629196 34 69392
2022-02-11 SC 13G/A SC 13G/A 0001193125-22-037244 005-91805 22622062 34 98623
2022-02-03 6-K FORM 6-K 0001171843-22-000721 001-39179 22586371 34 14915
2022-01-19 424B3 424B3 0001104659-22-004979 333-262050 22536124 33 1178663
2022-01-18 EFFECT xslEFFECTX01/primary_doc.xml F-1,,2022-01-18 16:00:00 9999999995-22-000163 333-262050 22536708 33 1665
2022-01-14 CORRESP filename1.htm 0001104659-22-004409 7620
2022-01-14 UPLOAD filename1.pdf 0000000000-22-000500 40124
2022-01-10 SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13DA1 0001072613-22-000026 005-91805 22520688 34 335814
2022-01-07 F-1 F-1 0001104659-22-002264 333-262050 22518262 33 1315446
2021-12-21 D xslFormDX01/primary_doc.xml 06b 0001231919-21-000092 021-426200 211510011 33 13789
2021-12-20 424B5 424B5 0001104659-21-151327 333-255089 211503357 33 1859155
2021-12-20 6-K FORM 6-K 0001104659-21-151325 001-39179 211503348 34 669464
2021-12-15 6-K FORM 6-K 0001104659-21-149825 001-39179 211493324 34 105438
2021-11-15 6-K FORM 6-K 0001171843-21-007893 001-39179 211406014 34 14712
2021-11-04 6-K FORM 6-K 0001104659-21-134002 001-39179 211377908 34 963432
2021-09-29 6-K FORM 6-K 0001171843-21-006692 001-39179 211289122 34 14426
2021-09-22 6-K FORM 6-K 0001171843-21-006588 001-39179 211268097 34 15829
2021-09-08 SC 13D/A SC 13D/A 0001104659-21-113568 005-91805 211240588 34 61594
2021-08-05 6-K FORM 6-K 0001104659-21-100324 001-39179 211146058 34 913110
2021-08-02 6-K FORM 6-K 0001171843-21-005337 001-39179 211134515 34 13584
2021-07-29 6-K FORM 6-K 0001171843-21-005231 001-39179 211124653 34 15074
2021-07-01 6-K FORM 6-K 0001171843-21-004633 001-39179 211063916 34 15756
2021-06-30 6-K FORM 6-K 0001104659-21-087037 001-39179 211060014 34 306844
2021-06-30 424B5 424B5 0001047469-21-001224 333-255089 211060007 33 1293806
2021-06-29 6-K FORM 6-K 0001171843-21-004572 001-39179 211055464 34 16014
2021-06-17 6-K FORM 6-K 0001171843-21-004385 001-39179 211023301 34 13836
2021-06-07 6-K FORM 6-K 0001171843-21-004139 001-39179 21998128 34 14872
2021-05-17 6-K FORM 6-K 0001171843-21-003552 001-39179 21927274 34 15214
2021-05-14 6-K FORM 6-K 0001171843-21-003514 001-39179 21921793 34 16048
2021-05-05 6-K FORM 6-K 0001104659-21-061314 001-39179 21891000 34 640251
2021-04-26 6-K FORM 6-K 0001171843-21-002733 001-39179 21851430 34 12698
2021-04-13 EFFECT xslEFFECTX01/primary_doc.xml F-3,,2021-04-13 16:00:00 9999999995-21-001414 333-255089 21824437 33 1608
2021-04-12 CORRESP filename1.htm 0001104659-21-049123 9368
2021-04-09 UPLOAD filename1.pdf 0000000000-21-004321 40030
2021-04-08 S-8 S-8 0001104659-21-048040 333-255124 21814950 33 386674
2021-04-08 6-K FORM 6-K 0001171843-21-002376 001-39179 21813698 34 12476
2021-04-07 F-3 F-3 0001047469-21-000882 333-255089 21812182 33 772344
2021-03-11 6-K FORM 6-K 0001171843-21-001671 001-39179 21731764 34 23585
2021-03-11 20-F 20-F 0001047469-21-000566 001-39179 21731748 34 12781757 1
2021-02-17 6-K FORM 6-K 0001171843-21-001074 001-39179 21642540 34 13691
2021-02-16 SC 13G d8798330_13g.htm 0000919574-21-001601 005-91805 21638828 34 137361
2021-02-16 6-K FORM 6-K 0001171843-21-001031 001-39179 21631767 34 15556
2021-02-12 SC 13G NONE 0001567619-21-003449 005-91805 21626808 34 69376
2021-02-10 SC 13G SC 13G 0001193125-21-036512 005-91805 21615276 34 116125
2021-02-01 UPLOAD filename1.pdf 0000000000-21-001230 42025
2021-01-22 SC 13D GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D 0001072613-21-000050 005-91805 21543235 34 380041
2021-01-21 6-K FORM 6-K 0001171843-21-000352 001-39179 21540300 34 14192
2021-01-12 6-K FORM 6-K 0001171843-21-000213 001-39179 21522428 34 14985
2021-01-08 424B4 424B4 0001047469-21-000043 333-251322 21518372 33 4528013
2021-01-07 6-K FORM 6-K 0001171843-21-000150 001-39179 21512796 34 14364
2021-01-06 EFFECT xslEFFECTX01/primary_doc.xml F-1,,2021-01-06 17:15:00 9999999995-21-000043 333-251322 21512894 33 1608
2021-01-06 CORRESP filename1.htm 0001104659-21-001205 16886
2021-01-06 F-1/A F-1/A 0001047469-21-000017 333-251322 21508799 33 4978027
2021-01-05 CORRESP filename1.htm 0001104659-21-001198 12790
2020-12-14 DEL AM DEL AM 0001104659-20-135270 333-251322 201386492 33 13176
2020-12-14 6-K FORM 6-K 0001171843-20-008532 001-39179 201385607 34 12950
2020-12-14 F-1 F-1 0001047469-20-005701 333-251322 201385534 33 4834118
2020-11-03 SC 13D SC 13D 0001104659-20-120940 005-91805 201283593 34 55531
2020-11-03 6-K FORM 6-K 0001104659-20-120682 001-39179 201281815 34 875082
2020-11-02 6-K FORM 6-K 0001171843-20-007448 001-39179 201278864 34 15571
2020-10-15 UPLOAD filename1.pdf 0000000000-20-009766 40365
2020-10-13 DRS filename1.htm 0001410578-20-000137 377-03653 201235017 33 4485921
2020-08-27 6-K FORM 6-K 0001171843-20-006121 001-39179 201138954 34 15013
2020-08-12 6-K 6-K 0001104659-20-093460 001-39179 201093977 34 1234129
2020-07-20 6-K FORM 6-K 0001171843-20-005029 001-39179 201034933 34 12544
2020-06-16 6-K FORM 6-K 0001171843-20-004382 001-39179 20964915 34 14039
2020-06-10 6-K FORM 6-K 0001171843-20-004265 001-39179 20953446 34 13331
2020-05-20 6-K 6-K 0001104659-20-063978 001-39179 20895663 34 829890
2020-05-19 6-K FORM 6-K 0001171843-20-003822 001-39179 20891531 34 14937
2020-05-11 UPLOAD filename1.pdf 0000000000-20-004127 42653
2020-04-27 POS AM POS AM 0001047469-20-002582 333-235554 20816986 33 3320083
2020-04-27 20-F 20-F 0001047469-20-002580 001-39179 20816974 34 12203526 1
2020-04-08 6-K FORM 6-K 0001171843-20-002470 001-39179 20781043 34 24249
2020-03-18 6-K 6-K 0001104659-20-035090 001-39179 20723728 34 33076
2020-03-06 6-K 6-K 0001104659-20-030079 001-39179 20693829 34 34062
2020-01-28 424B4 424B4 0001047469-20-000551 333-235554 20555642 33 3732849
2020-01-28 CERT 8A_Cert_ADXN.pdf 0001354457-20-000035 001-39179 20554368 34 205545
2020-01-27 EFFECT xslEFFECTX01/primary_doc.xml F-6,,2020-01-27 16:00:00 9999999995-20-000167 333-235561 20551234 33 1692
2020-01-27 EFFECT xslEFFECTX01/primary_doc.xml F-1,,2020-01-27 16:00:00 9999999995-20-000166 333-235554 20551233 33 1692
2020-01-23 CORRESP filename1.htm 0001104659-20-006230 10950
2020-01-23 CORRESP filename1.htm 0001104659-20-006229 20614
2020-01-23 F-1/A F-1/A 0001047469-20-000443 333-235554 20541468 33 3786629
2020-01-15 UPLOAD filename1.pdf 0000000000-20-000377 48158
2020-01-14 8-A12B 8-A12B 0001104659-20-003571 001-39179 20524885 34 24457
2020-01-14 F-1/A F-1A 0001047469-20-000221 333-235554 20524876 33 4028283
2020-01-13 CORRESP filename1.htm 0001104659-20-003569 15071
2019-12-31 UPLOAD filename1.pdf 0000000000-19-016886 42922
2019-12-18 F-6 e619246_f6-addex.htm 0001193805-19-001947 333-235561 191291683 33 528758
2019-12-17 CORRESP filename1.htm 0001104659-19-073483 27453
2019-12-17 F-1 F-1 0001047469-19-006857 333-235554 191290551 33 6103395
2019-12-16 SEC STAFF LETTER filename1.pdf 9999999997-19-007882 226614
2019-12-12 UPLOAD filename1.pdf 0000000000-19-016316 48525
2019-11-27 DRSLTR filename1.htm 0000912057-19-000443 55005
2019-11-27 DRS/A filename1.htm 0000912057-19-000442 377-02847 191253186 33 4917335
2019-10-24 UPLOAD filename1.pdf 0000000000-19-014823 59246
2019-09-26 SEC STAFF LETTER filename1.pdf 9999999997-19-007125 147502
2019-09-24 DRS filename1.htm 0000912057-19-000390 377-02847 191109070 33 5278511

Latest XBRL company facts

One latest value per concept from companyfacts (196 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 147.83M 2025-12-31 2025 FY 20-F 2026-05-15 0001104659-26-062447
ifrs-full AccrualsClassifiedAsCurrent AccrualsClassifiedAsCurrent CHF 420,368 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ActuarialAssumptionOfDiscountRates ActuarialAssumptionOfDiscountRates pure 0.01 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full ActuarialAssumptionOfExpectedRatesOfPensionIncreases ActuarialAssumptionOfExpectedRatesOfPensionIncreases pure 0 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full ActuarialAssumptionOfExpectedRatesOfSalaryIncreases ActuarialAssumptionOfExpectedRatesOfSalaryIncreases pure 0.01 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill CHF 182,348 2024-01-01 2024-12-31 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment CHF 1,273 2024-01-01 2024-12-31 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full AdditionsToRightofuseAssets AdditionsToRightofuseAssets CHF 2,000 2021-01-01 2021-12-31 2022 FY 20-F 2023-03-30 0001104659-23-038581
ifrs-full AdjustedWeightedAverageShares AdjustedWeightedAverageShares shares 99.44M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full AdjustmentsForDecreaseIncreaseInContractAssets AdjustmentsForDecreaseIncreaseInContractAssets CHF 10,387 2024-01-01 2024-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full AdjustmentsForDecreaseIncreaseInOtherFinancialAssets AdjustmentsForDecreaseIncreaseInOtherFinancialAssets CHF -498 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full AdjustmentsForDecreaseIncreaseInPrepaidExpenses AdjustmentsForDecreaseIncreaseInPrepaidExpenses CHF -81,430 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables CHF -22,926 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full AdjustmentsForDepreciationExpense AdjustmentsForDepreciationExpense CHF 4,236 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full AdjustmentsForFinanceCosts AdjustmentsForFinanceCosts CHF 686,886 2020-01-01 2020-12-31 2020 FY 20-F 2021-03-11 0001047469-21-000566
ifrs-full AdjustmentsForFinanceIncomeCost AdjustmentsForFinanceIncomeCost CHF -33,399 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full AdjustmentsForIncreaseDecreaseInContractLiabilities AdjustmentsForIncreaseDecreaseInContractLiabilities CHF -733,668 2021-01-01 2021-12-31 2023 FY 20-F 2024-04-18 0001104659-24-048532
ifrs-full AdjustmentsForIncreaseDecreaseInDeferredIncome AdjustmentsForIncreaseDecreaseInDeferredIncome CHF -244,298 2020-01-01 2020-12-31 2020 FY 20-F 2021-03-11 0001047469-21-000566
ifrs-full AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities CHF -38,401 2024-01-01 2024-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables CHF 347,082 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets CHF -127 2021-01-01 2021-12-31 2022 FY 20-F 2023-03-30 0001104659-23-038581
ifrs-full AdjustmentsForProvisions AdjustmentsForProvisions CHF 2,003 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full AdjustmentsForSharebasedPayments AdjustmentsForSharebasedPayments CHF 44,098 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full AdjustmentsForUndistributedProfitsOfAssociates AdjustmentsForUndistributedProfitsOfAssociates CHF -2.08M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full AmortisationIntangibleAssetsOtherThanGoodwill AmortisationIntangibleAssetsOtherThanGoodwill CHF 182,348 2024-01-01 2024-12-31 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ApplicableTaxRate ApplicableTaxRate pure 0.14 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-18 0001104659-24-048532
ifrs-full AssetbackedSecuritiesPercentageContributedToFairValueOfPlanAssets AssetbackedSecuritiesPercentageContributedToFairValueOfPlanAssets pure 0.123 2023-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full Assets Assets CHF 8.51M 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full AverageNumberOfEmployees AverageNumberOfEmployees employee 25 2021-01-01 2021-12-31 2022 FY 20-F 2023-03-30 0001104659-23-038581
ifrs-full BasicAndDilutedEarningsLossPerShare BasicAndDilutedEarningsLossPerShare CHF -0.48 2020-01-01 2020-12-31 2020 FY 20-F 2021-03-11 0001047469-21-000566
ifrs-full BasicEarningsLossPerShare BasicEarningsLossPerShare CHF/shares -0.03 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full BasicEarningsLossPerShareFromContinuingOperations BasicEarningsLossPerShareFromContinuingOperations CHF/shares -0.03 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full BasicEarningsLossPerShareFromDiscontinuedOperations BasicEarningsLossPerShareFromDiscontinuedOperations CHF/shares 0 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full Cash Cash CHF 2.30M 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full CashAndCashEquivalents CashAndCashEquivalents CHF 2.30M 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full CashAndCashEquivalentsPercentageContributedToFairValueOfPlanAssets CashAndCashEquivalentsPercentageContributedToFairValueOfPlanAssets pure 0.004 2023-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full CashFlowsFromUsedInFinancingActivities CashFlowsFromUsedInFinancingActivities CHF 747,185 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full CashFlowsFromUsedInInvestingActivities CashFlowsFromUsedInInvestingActivities CHF -737,356 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full CashFlowsFromUsedInOperatingActivities CashFlowsFromUsedInOperatingActivities CHF -1.02M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full CashOnHand CashOnHand CHF 115 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full CashOutflowForLeases CashOutflowForLeases CHF 100,000 2024-01-01 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full ComprehensiveIncome ComprehensiveIncome CHF -3.26M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ComprehensiveIncomeFromContinuingOperations ComprehensiveIncomeFromContinuingOperations CHF -3.38M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ComprehensiveIncomeFromDiscontinuedOperations ComprehensiveIncomeFromDiscontinuedOperations CHF 117,747 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ContractAssets ContractAssets CHF 40,907 2023-12-31 2023 FY 20-F 2024-04-18 0001104659-24-048532
ifrs-full ContractualCapitalCommitments ContractualCapitalCommitments CHF 0 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full CurrentAssets CurrentAssets CHF 2.66M 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings CHF 0 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full CurrentContractAssets CurrentContractAssets CHF 40,907 2023-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full CurrentContractLiabilities CurrentContractLiabilities CHF 733,668 2020-12-31 2021 FY 20-F 2022-03-10 0001104659-22-032171
ifrs-full CurrentDeferredIncomeOtherThanCurrentContractLiabilities CurrentDeferredIncomeOtherThanCurrentContractLiabilities CHF 234,978 2023-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full CurrentLeaseLiabilities CurrentLeaseLiabilities CHF 7,491 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full CurrentLiabilities CurrentLiabilities CHF 1.15M 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax CHF 82,500 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full CurrentPrepaidExpenses CurrentPrepaidExpenses CHF 162,839 2020-12-31 2021 FY 20-F 2022-03-10 0001104659-22-032171
ifrs-full CurrentPrepayments CurrentPrepayments CHF 251,079 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full CurrentServiceCostDefinedBenefitPlans CurrentServiceCostDefinedBenefitPlans CHF 15,043 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full DebtInstrumentsPercentageContributedToFairValueOfPlanAssets DebtInstrumentsPercentageContributedToFairValueOfPlanAssets pure 0.464 2023-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full DeferredIncome DeferredIncome CHF 86,481 2020-12-31 2020 FY 20-F 2021-03-11 0001047469-21-000566
ifrs-full DeferredIncomeClassifiedAsCurrent DeferredIncomeClassifiedAsCurrent CHF 86,481 2020-12-31 2020 FY 20-F 2021-03-11 0001047469-21-000566
ifrs-full DeferredIncomeClassifiedAsNoncurrent DeferredIncomeClassifiedAsNoncurrent CHF 165,390 2019-12-31 2020 FY 20-F 2021-03-11 0001047469-21-000566
ifrs-full DeferredIncomeOtherThanContractLiabilities DeferredIncomeOtherThanContractLiabilities CHF 324,210 2023-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full DeferredTaxAssets DeferredTaxAssets CHF 0 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full DefinedBenefitObligationAtPresentValue DefinedBenefitObligationAtPresentValue CHF 7.61M 2022-06-30 2022 Q2 6-K/A 2022-09-14 0001104659-22-099810
ifrs-full DepreciationExpense DepreciationExpense CHF 4,236 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full DepreciationPropertyPlantAndEquipment DepreciationPropertyPlantAndEquipment CHF 212 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full DepreciationRightofuseAssets DepreciationRightofuseAssets CHF 4,023 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full DerivativesPercentageContributedToFairValueOfPlanAssets DerivativesPercentageContributedToFairValueOfPlanAssets pure 0.024 2023-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full DilutedEarningsLossPerShare DilutedEarningsLossPerShare CHF/shares -0.03 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full DilutedEarningsLossPerShareFromContinuingOperations DilutedEarningsLossPerShareFromContinuingOperations CHF/shares -0.03 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full DilutedEarningsLossPerShareFromDiscontinuedOperations DilutedEarningsLossPerShareFromDiscontinuedOperations CHF/shares 0 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full DisposalsRightofuseAssets DisposalsRightofuseAssets CHF 7,408 2024-01-01 2024-12-31 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full EffectOfExchangeRateChangesOnCashAndCashEquivalents EffectOfExchangeRateChangesOnCashAndCashEquivalents CHF -32,025 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full EmployeeBenefitsExpense EmployeeBenefitsExpense CHF 145,538 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full Equity Equity CHF 7.21M 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full EquityAndLiabilities EquityAndLiabilities CHF 8.51M 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full EquityInstrumentsPercentageContributedToFairValueOfPlanAssets EquityInstrumentsPercentageContributedToFairValueOfPlanAssets pure 0.14 2023-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full EstimatedFinancialEffectOfContingentLiabilities EstimatedFinancialEffectOfContingentLiabilities CHF 0 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full EstimateOfContributionsExpectedToBePaidToPlan EstimateOfContributionsExpectedToBePaidToPlan CHF 28,000 2024-01-01 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets CHF 44,098 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ExpenseFromSharebasedPaymentTransactionsWithEmployees ExpenseFromSharebasedPaymentTransactionsWithEmployees CHF 4,287 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed CHF 1,545 2024-01-01 2024-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full FinanceCosts FinanceCosts CHF 13,322 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full FinanceIncome FinanceIncome CHF 3 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full FinanceIncomeCost FinanceIncomeCost CHF -13,319 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full GainsLossesOnChangesInEffectOfLimitingNetDefinedBenefitAssetToAssetCeilingExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans GainsLossesOnChangesInEffectOfLimitingNetDefinedBenefitAssetToAssetCeilingExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans CHF 9,496 2023-01-01 2023-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss CHF -11,945 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full GeneralAndAdministrativeExpense GeneralAndAdministrativeExpense CHF 1.06M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full GrossLeaseLiabilities GrossLeaseLiabilities CHF 47,739 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full IncomeTaxExpenseContinuingOperations IncomeTaxExpenseContinuingOperations CHF 0 2024-01-01 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges CHF -1.01M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full IncreaseDecreaseInNetDefinedBenefitLiabilityAsset IncreaseDecreaseInNetDefinedBenefitLiabilityAsset CHF -100,000 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full IncreaseDecreaseThroughExerciseOfWarrantsEquity IncreaseDecreaseThroughExerciseOfWarrantsEquity CHF 35,981 2023-01-01 2023-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full IncreaseDecreaseThroughSharebasedPaymentTransactions IncreaseDecreaseThroughSharebasedPaymentTransactions CHF 44,098 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment CHF -18,987 2024-01-01 2024-12-31 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full IncreaseDecreaseThroughTransfersRightofuseAssets IncreaseDecreaseThroughTransfersRightofuseAssets CHF -231,272 2024-01-01 2024-12-31 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities CHF 2,000 2021-01-01 2021-12-31 2022 FY 20-F 2023-03-30 0001104659-23-038581
ifrs-full InsuranceExpense InsuranceExpense CHF 91,857 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full InterestExpense InterestExpense CHF 365 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full InterestExpenseDefinedBenefitPlans InterestExpenseDefinedBenefitPlans CHF 10,799 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full InterestExpenseOnLeaseLiabilities InterestExpenseOnLeaseLiabilities CHF 1,012 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full InterestIncomeDefinedBenefitPlans InterestIncomeDefinedBenefitPlans CHF 9,721 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full InterestPaidClassifiedAsFinancingActivities InterestPaidClassifiedAsFinancingActivities CHF 1,377 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full InvestmentsInAssociatesAccountedForUsingEquityMethod InvestmentsInAssociatesAccountedForUsingEquityMethod CHF 5.01M 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full IssuedCapital IssuedCapital CHF 1.84M 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full IssueOfEquity IssueOfEquity CHF 4.28M 2019-01-01 2019-12-31 2021 FY 20-F 2022-03-10 0001104659-22-032171
ifrs-full KeyManagementPersonnelCompensation KeyManagementPersonnelCompensation CHF 240,584 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full KeyManagementPersonnelCompensationSharebasedPayment KeyManagementPersonnelCompensationSharebasedPayment CHF 43,428 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full LeaseLiabilities LeaseLiabilities CHF 41,994 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full LiabilityAssetOfDefinedBenefitPlans LiabilityAssetOfDefinedBenefitPlans CHF 111,947 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full LicenceFeeIncome LicenceFeeIncome CHF 4.88M 2018-01-01 2018-12-31 2020 FY 20-F 2021-03-11 0001047469-21-000566
ifrs-full LongtermBorrowings LongtermBorrowings CHF 0 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full LongtermDeposits LongtermDeposits CHF 7,086 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full MiscellaneousOtherOperatingIncome MiscellaneousOtherOperatingIncome CHF 1,870 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full NetDebt NetDebt CHF -3.31M 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full NetForeignExchangeLoss NetForeignExchangeLoss CHF 581,128 2020-01-01 2020-12-31 2020 FY 20-F 2021-03-11 0001047469-21-000566
ifrs-full NoncurrentAssets NoncurrentAssets CHF 5.85M 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities CHF 89,232 2023-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full NoncurrentDerivativeFinancialAssets NoncurrentDerivativeFinancialAssets CHF 509,067 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full NoncurrentFinancialAssets NoncurrentFinancialAssets CHF 7,086 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome CHF 285,962 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full NoncurrentLeaseLiabilities NoncurrentLeaseLiabilities CHF 30,896 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full NoncurrentLiabilities NoncurrentLiabilities CHF 142,843 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full NoncurrentRecognisedLiabilitiesDefinedBenefitPlan NoncurrentRecognisedLiabilitiesDefinedBenefitPlan CHF 111,947 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented NumberOfInstrumentsThatAreAntidilutiveInPeriodPresented EquityInstruments 63.25M 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-18 0001104659-24-048532
ifrs-full NumberOfSharesIssued NumberOfSharesIssued shares 32.85M 2020-12-31 2020 FY 20-F 2021-03-11 0001047469-21-000566
ifrs-full NumberOfSharesOutstanding NumberOfSharesOutstanding shares 141.19M 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full NumberOfSharesRepresentedByOneDepositaryReceipt NumberOfSharesRepresentedByOneDepositaryReceipt pure 120 2023-10-23 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full OperatingExpense OperatingExpense CHF 1.45M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full OtherAssetsPercentageContributedToFairValueOfPlanAssets OtherAssetsPercentageContributedToFairValueOfPlanAssets pure 0.017 2021-12-31 2022 FY 20-F 2023-03-30 0001104659-23-038581
ifrs-full OtherComprehensiveIncome OtherComprehensiveIncome CHF 53,219 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation CHF -1,088 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans CHF -202,389 2024-01-01 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full OtherCurrentAssets OtherCurrentAssets CHF 356,586 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full OtherCurrentFinancialAssets OtherCurrentFinancialAssets CHF 6,994 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full OtherEquityInterest OtherEquityInterest CHF 64.62M 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full OtherExpenseByNature OtherExpenseByNature CHF 380,109 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full OtherIncome OtherIncome CHF 107,430 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full OtherReserves OtherReserves CHF 31.23M 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ParValuePerShare ParValuePerShare CHF/shares 0.01 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full PastServiceCostDefinedBenefitPlans PastServiceCostDefinedBenefitPlans CHF -1,070 2024-01-01 2024-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full PaymentsForShareIssueCosts PaymentsForShareIssueCosts CHF 1.70M 2021-01-01 2021-12-31 2023 FY 20-F 2024-04-18 0001104659-24-048532
ifrs-full PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities CHF 3,607 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full PlanAssetsAtFairValue PlanAssetsAtFairValue CHF 7.48M 2022-06-30 2022 Q2 6-K/A 2022-09-14 0001104659-22-099810
ifrs-full PostemploymentBenefitExpenseDefinedBenefitPlans PostemploymentBenefitExpenseDefinedBenefitPlans CHF 16,121 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations CHF 57,673 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ProceedsFromExerciseOfWarrants ProceedsFromExerciseOfWarrants CHF 35,981 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-18 0001104659-24-048532
ifrs-full ProceedsFromIssuingShares ProceedsFromIssuingShares CHF 10.16M 2021-01-01 2021-12-31 2023 FY 20-F 2024-04-18 0001104659-24-048532
ifrs-full ProceedsFromSaleOrIssueOfTreasuryShares ProceedsFromSaleOrIssueOfTreasuryShares CHF 777,546 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ProfessionalFeesExpense ProfessionalFeesExpense CHF 622,635 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ProfitLoss ProfitLoss CHF -3.31M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity CHF -3.31M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects CHF -3.31M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ProfitLossBeforeTax ProfitLossBeforeTax CHF -3.43M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ProfitLossFromContinuingOperations ProfitLossFromContinuingOperations CHF -3.43M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity CHF -3.43M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects CHF -3.43M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ProfitLossFromDiscontinuedOperations ProfitLossFromDiscontinuedOperations CHF 117,747 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntity CHF 117,747 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects ProfitLossFromDiscontinuedOperationsAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects CHF 117,747 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ProfitLossFromOperatingActivities ProfitLossFromOperatingActivities CHF -1.34M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full PropertyPlantAndEquipment PropertyPlantAndEquipment CHF 919 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full PurchaseOfFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeClassifiedAsInvestingActivities PurchaseOfFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeClassifiedAsInvestingActivities CHF 285,962 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities CHF 14,795 2019-01-01 2019-12-31 2020 FY 20-F 2021-03-11 0001047469-21-000566
ifrs-full PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities CHF 0 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full RawMaterialsAndConsumablesUsed RawMaterialsAndConsumablesUsed CHF 4,021 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full RealEstatePercentageContributedToFairValueOfPlanAssets RealEstatePercentageContributedToFairValueOfPlanAssets pure 0.246 2023-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full ResearchAndDevelopmentExpense ResearchAndDevelopmentExpense CHF 390,520 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full RetainedEarnings RetainedEarnings CHF -356.68M 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans ReturnOnPlanAssetsExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans CHF 21,832 2024-01-01 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset CHF -106,340 2021-01-01 2021-12-31 2021 FY 20-F 2022-03-10 0001104659-22-032171
ifrs-full RevenueAndOperatingIncome RevenueAndOperatingIncome CHF 107,430 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full RevenueFromContractsWithCustomers RevenueFromContractsWithCustomers CHF 348,757 2024-01-01 2024-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full RevenueFromInterest RevenueFromInterest CHF 3 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full RightofuseAssets RightofuseAssets CHF 37,555 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full SaleOrIssueOfTreasuryShares SaleOrIssueOfTreasuryShares CHF 777,546 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ShareIssueRelatedCost ShareIssueRelatedCost CHF 7,037 2024-01-01 2024-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillNotBeReclassifiedToProfitOrLossNetOfTax ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillNotBeReclassifiedToProfitOrLossNetOfTax CHF -164,101 2024-01-01 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod CHF -2.08M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full SharePremium SharePremium CHF 266.94M 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates shares 43.16M 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full ShorttermDepositsClassifiedAsCashEquivalents ShorttermDepositsClassifiedAsCashEquivalents CHF 4.65M 2019-12-31 2020 FY 20-F 2021-03-11 0001047469-21-000566
ifrs-full SocialSecurityContributions SocialSecurityContributions CHF 11,550 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full SurplusDeficitInPlan SurplusDeficitInPlan CHF -164,251 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss CHF 321,494 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-18 0001104659-24-048532
ifrs-full TaxEffectOfForeignTaxRates TaxEffectOfForeignTaxRates CHF -1,658 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-18 0001104659-24-048532
ifrs-full TaxEffectOfTaxLosses TaxEffectOfTaxLosses CHF 1.68M 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-18 0001104659-24-048532
ifrs-full TaxExpenseIncomeAtApplicableTaxRate TaxExpenseIncomeAtApplicableTaxRate CHF -1.48M 2023-01-01 2023-12-31 2023 FY 20-F 2024-04-18 0001104659-24-048532
ifrs-full TradeAndOtherCurrentPayables TradeAndOtherCurrentPayables CHF 1.14M 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full TradeAndOtherCurrentPayablesToTradeSuppliers TradeAndOtherCurrentPayablesToTradeSuppliers CHF 640,087 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full TradeAndOtherCurrentReceivables TradeAndOtherCurrentReceivables CHF 38,439 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full TreasuryShares TreasuryShares CHF 738,489 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised CHF 175.50M 2024-12-31 2024 FY 20-F 2025-05-15 0001104659-25-049380
ifrs-full WagesAndSalaries WagesAndSalaries CHF 113,580 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663
ifrs-full WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16 WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16 pure 0.047 2018-12-31 2019 FY 20-F 2020-04-27 0001047469-20-002580
ifrs-full WeightedAverageShares WeightedAverageShares shares 99.44M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-09-30 0001104659-25-094663

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →